Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'.

Ramirez, Giuseppe A; Della-Torre, Emanuel; Moroni, Luca; Yacoub, Mona-Rita; Dagna, Lorenzo

Ramirez, Giuseppe A; Della-Torre, Emanuel; Moroni, Luca; Yacoub, Mona-Rita; Dagna, Lorenzo.

Ramirez GA; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milano, Italy ramirez.giuseppealvise@hsr.it.
Della-Torre E; Immunology, Università Vita Salute San Raffaele, Milano, Italy.
Moroni L; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milano, Italy.
Yacoub MR; Immunology, Università Vita Salute San Raffaele, Milano, Italy.
Dagna L; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milano, Italy.

Ann Rheum Dis ; 80(10): e159, 2021 Oct.

Article in English | MEDLINE | ID: covidwho-1242192

Subject(s)

COVID-19 Vaccines; Immunosuppression Therapy; Cohort Studies; Humans; Immunogenicity, Vaccine; RNA, Messenger

Keywords

COVID-19; autoimmune diseases; immune system diseases; vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunosuppression Therapy / COVID-19 Vaccines Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2021-220539

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google